Riskpilot← Back to searchSign inGet full accessAbilis Ortopedi AB
ABActiveOrg 5593783052Ingemarsgatan 2Medical specialists activities · NACE 8622Est. 20221 employees
Revenue 2025
SEK 577K
EBITDA margin
-3.4%
-9741% vs 2024
Equity ratio
6.1%
Financial strength
Net profit 2025
SEK -19K
-3292% vs 2024
| Revenue | SEK 577K | — |
| EBITDA | SEK -20K | -9741% |
| Net profit | SEK -19K | -3292% |
| Total assets | SEK 417K | +82% |
| Equity | SEK 25K | +6% |
| Employees | 1 | — |
Legal name
Abilis Ortopedi AB
Org number
5593783052
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 maj 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet skall vara att bedriva en specialistklinik inriktat på diagnostik, behandling och kirurgi av led och muskuloskeletala besvär. Vi erbjuder högspecialiserad vård för patienter med artros, idrottsskador, överbelastningsskador och andra ortopediska tillstånd samt därmed förenlig verksamhet.
Address
Ingemarsgatan 2
Email
info@abilisortopedi.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 75 | 0 | 577 |
| Staff expenses | −73 | −0 | −144 |
| EBITDA | −2 | −0 | −20 |
| Depreciation & amort. | — | — | — |
| EBIT | −2 | −0 | −20 |
| Net financials | 0 | 1 | 1 |
| Profit before tax | −1 | 1 | −19 |
| Tax | −0 | −0 | — |
| Net profit | −1 | 1 | −19 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 26 | 229 | 417 |
| Equity | 24 | 24 | 25 |
| Long-term debt | — | — | — |
| Short-term debt | 2 | 205 | 391 |
| Total debt | 2 | 205 | 391 |
EBITDA margin
-3.4%
This company
15.8%
Market median
-122% vs market
20232025
Equity ratio
6.1%
This company
38.2%
Market median
-84% vs market
20232025
Return on equity
-73.3%
This company
18.4%
Market median
-498% vs market
20232025
Net profit margin
-3.2%
This company
8.1%
Market median
-140% vs market
20232025
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20232025
Debt / equity
15.37×
This company
0.62×
Market median
-2379% vs market
20232025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-02 – 2023-06-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2026 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abilis Ortopedi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Anders Bergtoft | Chairman | 0 companies |
| Vasileios Sarakatsianos | Chairman | 0 companies |
| Johanna Maria Bergtoft | Deputy Board Member | 0 companies |
| Maria Königsmark | Board of Directors | 0 companies |
| Martin Königsmark | Deputy Board Member | 0 companies |
| Kristina Königsmark | Deputy Board Member | 0 companies |
| Kristian-Pantelis Xintaris | Board of Directors | 0 companies |
| Johan David Leandersson | Board of Directors | 0 companies |